Back to search results

Anxiety Intervention for Latino Older Adults with Cancer and Their Caregivers

This study is looking at a program called Managing Anxiety from Cancer (MAC) to see if it helps Latino older adults with cancer and their caregivers manage anxiety. MAC is a psychotherapy (talk therapy) program with seven sessions, each lasting 45-60 minutes. These sessions are given by video or phone by trained mental health professionals. The study wants to see how many people complete all parts of the study. You might be able to join if you are a Latino older adult with cancer, aged 65 or older, and are currently getting cancer treatment or finished treatment within the last 18 months. Caregivers of these individuals can also participate. The study is currently unclear about its recruitment status and plans to enroll 60 participants.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 60 participants.
What's involved
Participants will take part in seven psychotherapy sessions, each lasting 45-60 minutes, delivered via videoconference or telephone.
Compensation
Not stated in the trial record.
Follow-up
The study will measure how many participants complete all study procedures at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06305741

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

Recruiting
NAAges 40+InterventionalSupportive care
Memorial Sloan Kettering Cancer Center
~60 participants
Updated 2026-03-06 on ClinicalTrials.gov
What's tested:Managing Anxiety from Cancer (MAC)

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
percentage of participants to complete all study procedures
Measured over 1 year

Conditions

Cancer Patients
Care Givers

Explore related trials

CaregiversMalignant Neoplasm

Where it's being run

7 sites across 2 states
New York4
New Jersey3

Study leadership

  • Kelly McConnell, PhD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Kelly McConnell, PhD
[email protected]
646-888-0026
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

As per medical record or self-report, is currently age 65 years or older
As per medical record or self-report, currently receiving active cancer treatment OR is within eighteen months of completing active treatment which includes surgery, chemotherapy, radiation, and immunotherapy.
As per self-report, identifies as Latino and/or Hispanic Ethnicity
Scores ≥6 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)
Per self-report, fluent in English and/or Spanish\*\* \*\* Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study:
Per OAC report, is primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) for the eligible OAC patient
As per self-report, is age 40 years or older
Per self-report, fluent in English and/or Spanish\*\* \*\* Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study:

Exclusion

As per medical record or self-report, currently receiving psychotherapy
As per medical record or self-report, taking psychotropic medications for \< 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study
As per medical record or self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder
Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 11
Per research staff judgment and/or self-report, too ill or weak to complete study procedures
Per medical record or self-report, receiving hospice care at the time of enrollment
As per self-report, currently receiving psychotherapy
As per self-report, taking psychotropic medications for \< 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study
As per self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder
Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 11
Per research staff judgment and/or self-report, too ill or weak to complete study procedures

What this trial measures

  • percentage of participants to complete all study procedures1 year